Todd Foley - Jun 3, 2021 Form 4 Insider Report for Repare Therapeutics Inc. (RPTX)

Role
Director
Signature
/s/ Todd Foley
Stock symbol
RPTX
Transactions as of
Jun 3, 2021
Transactions value $
-$820,274
Form type
4
Date filed
6/7/2021, 06:40 PM
Previous filing
Jun 2, 2021
Next filing
Jun 10, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPTX Common Shares Sale -$314K -9.82K -0.41% $31.92 2.37M Jun 3, 2021 See Footnote F1, F2, F3, F4
transaction RPTX Common Shares Sale -$109K -3.54K -0.15% $30.80 2.37M Jun 4, 2021 See Footnote F1, F5, F6, F7
transaction RPTX Common Shares Sale -$64.7K -2.07K -0.09% $31.28 2.37M Jun 4, 2021 See Footnote F1, F8, F9, F10
transaction RPTX Common Shares Sale -$32.5K -1.06K -0.04% $30.74 2.37M Jun 7, 2021 See Footnote F1, F11, F12, F13
transaction RPTX Common Shares Sale -$24.2K -749 -0.03% $32.25 2.37M Jun 7, 2021 See Footnote F1, F14, F15, F16
transaction RPTX Common Shares Sale -$276K -8.38K -0.35% $32.96 2.36M Jun 7, 2021 See Footnote F1, F17, F18, F19
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on 3/31/2021.
F2 The shares were sold as follows: 9,497 by MPM BioVentures 2014, L.P. ("BV 2014") and 327 by MPM Asset Management Investors BV2014 LLC ("AM BV2014").
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.35 to $32.265 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The shares are held as follows: 2,163,535 by BV 2014, 135,843 by MPM BioVentures 2014(B), L.P. ("BV 2014(B)") and 74,470 by AM BV2014. MPM BioVentures 2014 GP LLC and MPM BioVentures 2014 LLC ("BV LLC") are the direct and indirect general partners of BV 2014 and BV 2014(B). BV LLC is the manager of AM BV2014. Todd Foley is a managing director of BV LLC. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
F5 The shares were sold as follows: 3,426 by BV 2014 and 118 by AM BV2014.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.10 to $31.09 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F7 The shares are held as follows: 2,160,109 by BV 2014, 135,843 by BV 2014(B) and 74,352 by AM BV2014. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
F8 The shares were sold as follows: 1,999 by BV 2014 and 69 by AM BV2014.
F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.10 to $31.54 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F10 The shares are held as follows: 2,158,110 by BV 2014, 135,843 by BV 2014(B) and 74,283 by AM BV2014. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
F11 The shares were sold as follows: 1,023 by BV 2014 and 35 by AM BV2014.
F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.41 to $31.25 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F13 The shares are held as follows: 2,157,087 by BV 2014, 135,843 by BV 2014(B) and 74,248 by AM BV2014. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
F14 The shares were sold as follows: 724 by BV 2014 and 25 by AM BV2014.
F15 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.50 to $32.49 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F16 The shares are held as follows: 2,156,363 by BV 2014, 135,843 by BV 2014(B) and 74,223 by AM BV2014. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
F17 The shares were sold as follows: 8,100 by BV 2014 and 279 by AM BV2014.
F18 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.50 to $33.15 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F19 The shares are held as follows: 2,148,263 by BV 2014, 135,843 by BV 2014(B) and 73,944 by AM BV2014. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.